Inventors:
Hongyan Guo - Foster City CA, US
Darryl Kato - Foster City CA, US
Thorsten A. Kirschberg - Foster City CA, US
Hongtao Liu - Foster City CA, US
John O. Link - Foster City CA, US
Michael L. Mitchell - Foster City CA, US
Jay P. Parrish - Foster City CA, US
Jianyu Sun - Foster City CA, US
James Taylor - Foster City CA, US
Elizabeth M. Bacon - Foster City CA, US
Eda Canales - Foster City CA, US
Aesop Cho - Foster City CA, US
Choung U. Kim - Foster City CA, US
Jeromy J. Cottell - Foster City CA, US
Manoj C. Desai - Foster City CA, US
Randall L. Halcomb - Foster City CA, US
Scott E. Lazerwith - Foster City CA, US
Richard L. Mackman - Foster City CA, US
Hyung-Jung Pyun - Foster City CA, US
Joseph H. Saugier - Foster City CA, US
James D. Trenkle - Foster City CA, US
Winston C. Tse - Foster City CA, US
William J. Watkins - Foster City CA, US
Lianhong Xu - Foster City CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A61K 31/4178
A61K 31/435
A61K 31/55
A61K 31/438
A61K 31/496
A61K 31/5415
A61K 31/708
A61K 31/7052
A61K 38/21
C07D 403/14
C07D 401/14
C07D 417/14
A61P 31/14
US Classification:
424 854, 424 857, 514217, 5142258, 51425405, 514278, 514299, 514397, 514 43, 544370, 544 35, 546112, 546 16, 5483131, 540587
Abstract:
The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.